Abstract
Summary
Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.
The global Animal Biotechnology market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Animal Biotechnology Industry Forecast” looks at past sales and reviews total world Animal Biotechnology sales in 2023, providing a comprehensive analysis by region and market sector of projected Animal Biotechnology sales for 2024 through 2030. With Animal Biotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Biotechnology industry.
This Insight Report provides a comprehensive analysis of the global Animal Biotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Biotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Biotechnology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Biotechnology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Biotechnology.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 184%.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Biotechnology market by product type, application, key players and key regions and countries.
Segmentation by type
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines
Segmentation by application
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis
The global Animal Biotechnology market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Animal Biotechnology Industry Forecast” looks at past sales and reviews total world Animal Biotechnology sales in 2023, providing a comprehensive analysis by region and market sector of projected Animal Biotechnology sales for 2024 through 2030. With Animal Biotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Biotechnology industry.
This Insight Report provides a comprehensive analysis of the global Animal Biotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Biotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Biotechnology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Biotechnology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Biotechnology.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 184%.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Biotechnology market by product type, application, key players and key regions and countries.
Segmentation by type
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines
Segmentation by application
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Animal Biotechnology Market Size 2019-2030
2.1.2 Animal Biotechnology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Animal Biotechnology Segment by Type
2.2.1 Diagnostic Tests
2.2.2 Drugs
2.2.3 Reporductive & Genetic Produtcs
2.2.4 Vaccines
2.3 Animal Biotechnology Market Size by Type
2.3.1 Animal Biotechnology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Animal Biotechnology Market Size Market Share by Type (2019-2024)
2.4 Animal Biotechnology Segment by Application
2.4.1 Preventive Care for Animals
2.4.2 Development of Animal Pharmaceuticals
2.4.3 Food Safety and Drug Development
2.4.4 Others
2.5 Animal Biotechnology Market Size by Application
2.5.1 Animal Biotechnology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Animal Biotechnology Market Size Market Share by Application (2019-2024)
3 Animal Biotechnology Market Size by Player
3.1 Animal Biotechnology Market Size Market Share by Players
3.1.1 Global Animal Biotechnology Revenue by Players (2019-2024)
3.1.2 Global Animal Biotechnology Revenue Market Share by Players (2019-2024)
3.2 Global Animal Biotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Animal Biotechnology by Regions
4.1 Animal Biotechnology Market Size by Regions (2019-2024)
4.2 Americas Animal Biotechnology Market Size Growth (2019-2024)
4.3 APAC Animal Biotechnology Market Size Growth (2019-2024)
4.4 Europe Animal Biotechnology Market Size Growth (2019-2024)
4.5 Middle East & Africa Animal Biotechnology Market Size Growth (2019-2024)
5 Americas
5.1 Americas Animal Biotechnology Market Size by Country (2019-2024)
5.2 Americas Animal Biotechnology Market Size by Type (2019-2024)
5.3 Americas Animal Biotechnology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal Biotechnology Market Size by Region (2019-2024)
6.2 APAC Animal Biotechnology Market Size by Type (2019-2024)
6.3 APAC Animal Biotechnology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Animal Biotechnology by Country (2019-2024)
7.2 Europe Animal Biotechnology Market Size by Type (2019-2024)
7.3 Europe Animal Biotechnology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Animal Biotechnology by Region (2019-2024)
8.2 Middle East & Africa Animal Biotechnology Market Size by Type (2019-2024)
8.3 Middle East & Africa Animal Biotechnology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Animal Biotechnology Market Forecast
10.1 Global Animal Biotechnology Forecast by Regions (2025-2030)
10.1.1 Global Animal Biotechnology Forecast by Regions (2025-2030)
10.1.2 Americas Animal Biotechnology Forecast
10.1.3 APAC Animal Biotechnology Forecast
10.1.4 Europe Animal Biotechnology Forecast
10.1.5 Middle East & Africa Animal Biotechnology Forecast
10.2 Americas Animal Biotechnology Forecast by Country (2025-2030)
10.2.1 United States Animal Biotechnology Market Forecast
10.2.2 Canada Animal Biotechnology Market Forecast
10.2.3 Mexico Animal Biotechnology Market Forecast
10.2.4 Brazil Animal Biotechnology Market Forecast
10.3 APAC Animal Biotechnology Forecast by Region (2025-2030)
10.3.1 China Animal Biotechnology Market Forecast
10.3.2 Japan Animal Biotechnology Market Forecast
10.3.3 Korea Animal Biotechnology Market Forecast
10.3.4 Southeast Asia Animal Biotechnology Market Forecast
10.3.5 India Animal Biotechnology Market Forecast
10.3.6 Australia Animal Biotechnology Market Forecast
10.4 Europe Animal Biotechnology Forecast by Country (2025-2030)
10.4.1 Germany Animal Biotechnology Market Forecast
10.4.2 France Animal Biotechnology Market Forecast
10.4.3 UK Animal Biotechnology Market Forecast
10.4.4 Italy Animal Biotechnology Market Forecast
10.4.5 Russia Animal Biotechnology Market Forecast
10.5 Middle East & Africa Animal Biotechnology Forecast by Region (2025-2030)
10.5.1 Egypt Animal Biotechnology Market Forecast
10.5.2 South Africa Animal Biotechnology Market Forecast
10.5.3 Israel Animal Biotechnology Market Forecast
10.5.4 Turkey Animal Biotechnology Market Forecast
10.5.5 GCC Countries Animal Biotechnology Market Forecast
10.6 Global Animal Biotechnology Forecast by Type (2025-2030)
10.7 Global Animal Biotechnology Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bayer AG
11.1.1 Bayer AG Company Information
11.1.2 Bayer AG Animal Biotechnology Product Offered
11.1.3 Bayer AG Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer AG Main Business Overview
11.1.5 Bayer AG Latest Developments
11.2 Merck &, Inc.
11.2.1 Merck &, Inc. Company Information
11.2.2 Merck &, Inc. Animal Biotechnology Product Offered
11.2.3 Merck &, Inc. Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck &, Inc. Main Business Overview
11.2.5 Merck &, Inc. Latest Developments
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Information
11.3.2 Pfizer, Inc. Animal Biotechnology Product Offered
11.3.3 Pfizer, Inc. Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer, Inc. Main Business Overview
11.3.5 Pfizer, Inc. Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Animal Biotechnology Product Offered
11.4.3 Sanofi Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Biogenesis Bago
11.5.1 Biogenesis Bago Company Information
11.5.2 Biogenesis Bago Animal Biotechnology Product Offered
11.5.3 Biogenesis Bago Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Biogenesis Bago Main Business Overview
11.5.5 Biogenesis Bago Latest Developments
11.6 Santa Cruz Biotechnology, Inc.
11.6.1 Santa Cruz Biotechnology, Inc. Company Information
11.6.2 Santa Cruz Biotechnology, Inc. Animal Biotechnology Product Offered
11.6.3 Santa Cruz Biotechnology, Inc. Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Santa Cruz Biotechnology, Inc. Main Business Overview
11.6.5 Santa Cruz Biotechnology, Inc. Latest Developments
11.7 Boehringer Inghlem
11.7.1 Boehringer Inghlem Company Information
11.7.2 Boehringer Inghlem Animal Biotechnology Product Offered
11.7.3 Boehringer Inghlem Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Inghlem Main Business Overview
11.7.5 Boehringer Inghlem Latest Developments
11.8 Virbac Inc.
11.8.1 Virbac Inc. Company Information
11.8.2 Virbac Inc. Animal Biotechnology Product Offered
11.8.3 Virbac Inc. Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Virbac Inc. Main Business Overview
11.8.5 Virbac Inc. Latest Developments
11.9 Zoetis
11.9.1 Zoetis Company Information
11.9.2 Zoetis Animal Biotechnology Product Offered
11.9.3 Zoetis Animal Biotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Zoetis Main Business Overview
11.9.5 Zoetis Latest Developments
12 Research Findings and Conclusion